4th Quarter - Report

HOLLAND & KNIGHT LLP for TEVA PHARMACEUTICALS USA, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Global supply chain issues; National Defense Authorization Act; Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133).

Foreign entity interest: Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries, LTD, headquartered in Israel.

LobbyistCovered position, as disclosed
CHRISTOPHER ARMSTRONG —
RICHARD M GOLD New —
MICHAEL WERNER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 133 (116th)

Pharmacy PHA

Global supply chain issues; National Defense Authorization Act; Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133).

Foreign entity interest: Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries, LTD, headquartered in Israel.

LobbyistCovered position, as disclosed
CHRISTOPHER ARMSTRONG —
RICHARD M GOLD New —
MICHAEL WERNER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 133 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.